CLAUDIA ANTHONY: Open Payments
NPI 1972530632 · BRANDON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 41 payments from 13 companies in 2025. Trend: 2023 $683 · 2024 $489 · 2025 $720
Food & beverage: $675Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $146 |
| Lilly USA, LLC | 6 | $137 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Novo Nordisk Inc | 5 | $82 |
| PFIZER INC. | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: UBRELVY, BREZTRI, MOUNJARO, SHINGRIX, VRAYLAR, Rybelsus, TRELEGY ELLIPTA, JARDIANCE.
Industry payments across MS — which companies pay providers there.
